First, as mentioned above, both NOS isoforms were found to be increased in the CSF of AD patients within the APOE ε3 subgroup, while their levels were similar in the APOE ε4 subgroup with respect to healthy controls. This evidence concerns the gene APOE and Alzheimer disease.